Effect of bupropion on CYP2B6 and CYP3A4 catalytic activity, immunoreactive protein and mRNA levels in primary human hepatocytes: comparison with rifampicin
- 1 September 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 55 (9), 1229-1239
- https://doi.org/10.1211/0022357021657
Abstract
Animals treated with multiple doses of bupropion have had increased bupropion clearance or increased liver weight, suggesting induction of drug-metabolizing activity. The possibility of cytochrome p450 (CYP) induction by bupropion (10 μM) was evaluated in-vitro by comparing catalytic activity, immunoreactive protein and CYP mRNA levels from human hepatocytes in primary culture versus cells treated with vehicle (0.5% methanol) and with rifampicin (rifampin) as a positive control. mRNA levels were analysed using a branched DNA luminescent assay. CYP2B6 activity, protein and mRNA levels were increased by 2.5, 1.5 and 2.1 fold, respectively, by 20 μM rifampicin. However, 10 μM bupropion minimally altered CYP2B6 (1.4, 1.1, 0.8 fold). Although CYP3A4 activity, protein, and mRNA levels were increased by 4.0, 2.3, and 14.0 fold, respectively, by 20 μM rifampicin, 10 μM bupropion minimally altered CYP3A4 (1.4, 1.0, 0.8 fold). Rifampicin (20 μM) increased CYP2E1 protein by 2.1 fold, while 10 μM bupropion minimally altered CYP2E1 protein (1.2 fold). Overall, results of this study suggest that multiple doses of bupropion are not likely to induce CYP2B6, 3A4 or 2E1 in-vivo in man.Keywords
This publication has 24 references indexed in Scilit:
- Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A genePharmacogenetics, 2001
- A Prospective Safety Surveillance Study for Bupropion Sustained-Release in the Treatment of DepressionThe Journal of Clinical Psychiatry, 1998
- Pharmacokinetics of Bupropion and its Metabolites in Cigarette Smokers versus NonsmokersThe Journal of Clinical Pharmacology, 1997
- Hepatotoxicity of Antitubercular TreatmentsDrug Safety, 1996
- The Fetal Specific GeneCYP3A7Is Inducible by Rifampicin in Adult Human Hepatocytes in Primary CultureBiochemical and Biophysical Research Communications, 1996
- Rifampin drastically reduces plasma concentrations and effects of oral midazolamClinical Pharmacology & Therapeutics, 1996
- Evidence that the Acute Behavioral and Electrophysiological Effects of Bupropion (Wellbutrin®) Are Mediated by a Noradrenergic MechanismNeuropsychopharmacology, 1994
- Use of single sample clearance estimates of cytochrome P450 substrates to characterize human hepatic CYP statusin vivoXenobiotica, 1993
- Bupropion in DepressionArchives of General Psychiatry, 1988
- Determination of Bupropion and Its Major Basic Metabolites in Plasma by Liquid Chromatography With Dual-Wavelength Ultraviolet DetectionJournal of Pharmaceutical Sciences, 1984